Search

everythinglearnresearchcommunity

for

Search:↓

Deleting vitamin D and calcium receptors in skin cells increases skin cancer risk by reducing DNA repair and stress response.

Nephronectin is linked to worse breast cancer outcomes and helps cancer spread.

Hoxc8 gene helps start mammary gland development by controlling specific signals.

Androgen receptor inactivation delays skin cancer onset and reduces incidence in mice, with gender differences in susceptibility.

Nelfb is essential for dermal fat development and survival.

Loss of TET2 increases the risk of skin and oral cancer.

Repetin is a protein involved in skin and hair development, binding calcium and compensating for other proteins when needed.

HPV8 causes skin cancer by expanding specific skin stem cells.

Sfrp2 increases during hair follicle catagen phase and slows keratinocyte growth.

FERONIA and LRX proteins help control cell growth in plants by regulating vacuole expansion.

CD34+ and CD34- melanocyte stem cells have different regenerative abilities.

EGFR inhibitors in breast cancer treatment can cause serious skin issues affecting patient quality of life.

PBX1 reduces aging and cell death in stem cells by boosting SIRT1 and lowering PARP1.

As skin cells mature, vitamin D receptor levels decrease while retinoid X receptor α levels increase.

Targeting NCoR1 can help treat heart enlargement and dysfunction.

Using polyethylenimine-DNA to deliver the hTERT gene can stimulate hair growth and may be useful in treating hair loss, but there could be potential cancer risks.

The topical inhibitor CUR61414 was not effective in treating basal cell carcinoma in human trials.

PKC ε increases hair follicle stem cell turnover and may raise skin cancer risk.

Targeted cancer therapies can cause skin side effects, but activating SOS in the skin may help reduce them.

Dormant melanoma cells in mice interact minimally with memory T cells due to a suppressive tumor environment.

Genetic testing is crucial for diagnosing and managing non-Herlitz junctional epidermolysis bullosa.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

The glucocorticoid receptor helps protect skin from tumors and other issues.

Calretinin can help identify certain skin structures and tumors.

HPV does not cause aggressive cancer in RDEB patients.

Different types of skin gland tumors have unique genetic traits, which can guide personalized treatments.

The study concluded that both estrogen and androgen receptors, which decrease with age, are linked to skin aging and may be hormonally regulated.

Erlotinib can cause hair loss as a side effect.

Signals from skin cells controlled by Rac proteins help turn certain precursor cells into white fat cells.